Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular skin proteins, primarily located in the stratum corneum and upper layers of the epidermis, serve as the primary pharmacological target for astringent agents like aluminum acetate (StatPearls, 2023). These proteins, including keratin and various structural components, undergo precipitation and coagulation upon contact with aluminum ions (PubChem, CID 9330). This biochemical reaction leads to the contraction of tissues, a reduction in capillary permeability, and the drying of exudative (weeping) skin lesions (ScienceDirect, 2021). By forming a protective layer of precipitated protein, aluminum acetate helps alleviate symptoms of inflammatory skin conditions such as contact dermatitis, poison ivy, and insect bites (NIH, 2022). While not a single receptor-mediated target, the collective interaction with these proteins is essential for the therapeutic efficacy of topical astringent solutions.
Protein precipitation and coagulation leading to tissue contraction and reduced exudation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular skin proteins.